Literature DB >> 31406411

Upregulation of gametocytogenesis in anti-malarial drug-resistant Plasmodium falciparum.

Thavamani Rajapandi1.   

Abstract

The deadliest form of human malaria is primarily caused by the protozoan parasite Plasmodium falciparum. These parasites establish pathogenicity in the human host with a very low number of sexual forms or gametocytes, which are transmitted to the mosquitoes. Several studies have reported that exposing artemisinin-sensitive P. falciparum rings to a low concentration of dihydroartemisinin (DHA) results in dormancy, and the artemisinin-induced dormant (AID) forms are recovered into normal growth stages after 5-20 days. In this study, artemisinin-resistant P. falciparum parasites were tested for the development of AID forms and their recovery. Interestingly, it was found that exposure of an asynchronous culture of artemisinin-resistant P. falciparum IPC 5202 to DHA, a line carrying a mutation in the PfK13 gene that is linked to artemisinin resistance, also results in dormancy. Both the ring and some late stages of these AID forms recovered after 10-15 days. Furthermore, a high proportion of the recovered dormant forms developed into sexual forms or gametocytes after 3-4 weeks, which is almost a 7-8 times higher rate of conversion of asexual to sexual forms (gametocytes) or the malaria transmissible forms. In contrast, only early ring forms of artemisinin-sensitive parasites recovered slowly, and additional exposure of these parasites to artemisinin resulted in complete clearance within a week. This is in contrast to the resistant parasites exposed to a second dose of artemisinin, which resulted in a very high rate of dormancy and recovery into sexual forms or gametocytes.

Entities:  

Keywords:  Dihydroartemisinin; Gametocytes; Plasmodium falciparum; Protozoan; Resistance

Year:  2019        PMID: 31406411      PMCID: PMC6667595          DOI: 10.1007/s12639-019-01110-w

Source DB:  PubMed          Journal:  J Parasit Dis        ISSN: 0971-7196


  32 in total

1.  Plasmodium falciparum dhfr but not dhps mutations associated with sulphadoxine-pyrimethamine treatment failure and gametocyte carriage in northern Ghana.

Authors:  Frank P Mockenhaupt; J Teun Bousema; Teunis A Eggelte; Jonas Schreiber; Stephan Ehrhardt; Nasstasja Wassilew; Rowland N Otchwemah; Robert W Sauerwein; Ulrich Bienzle
Journal:  Trop Med Int Health       Date:  2005-09       Impact factor: 2.622

Review 2.  The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum.

Authors:  Jacques Le Bras; Rémy Durand
Journal:  Fundam Clin Pharmacol       Date:  2003-04       Impact factor: 2.748

3.  Commitment to sexual differentiation in the human malaria parasite, Plasmodium falciparum.

Authors:  T G Smith; P Lourenço; R Carter; D Walliker; L C Ranford-Cartwright
Journal:  Parasitology       Date:  2000-08       Impact factor: 3.234

4.  Commitment to the production of male and female gametocytes in the human malaria parasite Plasmodium falciparum.

Authors:  F Silvestrini; P Alano; J L Williams
Journal:  Parasitology       Date:  2000-11       Impact factor: 3.234

5.  A randomized, placebo-controlled, double-blind trial on sulfadoxine-pyrimethamine alone or combined with artesunate or amodiaquine in uncomplicated malaria.

Authors:  Frank P Mockenhaupt; Stephan Ehrhardt; Stephen Y Dzisi; J Teun Bousema; Nasstasja Wassilew; Jonas Schreiber; Sylvester D Anemana; Jakob P Cramer; Rowland N Otchwemah; Robert W Sauerwein; Teunis A Eggelte; Ulrich Bienzle
Journal:  Trop Med Int Health       Date:  2005-06       Impact factor: 2.622

6.  Combination therapy counteracts the enhanced transmission of drug-resistant malaria parasites to mosquitoes.

Authors:  Rachel L Hallett; Colin J Sutherland; Neal Alexander; Rosalynn Ord; Musa Jawara; Chris J Drakeley; Margaret Pinder; Gijs Walraven; Geoffrey A T Targett; Ali Alloueche
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

7.  Determinants of treatment response to sulfadoxine-pyrimethamine and subsequent transmission potential in falciparum malaria.

Authors:  Fabián Méndez; Alvaro Muñoz; Gabriel Carrasquilla; Diana Jurado; Myriam Arévalo-Herrera; Joseph F Cortese; Christopher V Plowe
Journal:  Am J Epidemiol       Date:  2002-08-01       Impact factor: 4.897

8.  Extracellular lysines on the plasmodial surface anion channel involved in Na+ exclusion.

Authors:  Jamieson V Cohn; Abdulnaser Alkhalil; Marissa A Wagner; Thavamani Rajapandi; Sanjay A Desai
Journal:  Mol Biochem Parasitol       Date:  2003-11       Impact factor: 1.759

9.  Artesunate combinations for treatment of malaria: meta-analysis.

Authors:  M Adjuik; A Babiker; P Garner; P Olliaro; W Taylor; N White
Journal:  Lancet       Date:  2004-01-03       Impact factor: 79.321

Review 10.  Gametocytogenesis: the puberty of Plasmodium falciparum.

Authors:  Arthur M Talman; Olivier Domarle; F Ellis McKenzie; Frédéric Ariey; Vincent Robert
Journal:  Malar J       Date:  2004-07-14       Impact factor: 2.979

View more
  1 in total

1.  Artemisinin exposure at the ring or trophozoite stage impacts Plasmodium falciparum sexual conversion differently.

Authors:  Harvie P Portugaliza; Shinya Miyazaki; Fiona Ja Geurten; Christopher Pell; Anna Rosanas-Urgell; Chris J Janse; Alfred Cortés
Journal:  Elife       Date:  2020-10-21       Impact factor: 8.140

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.